Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
Kyu Yeon Hur (Hur KY), Mee Kyoung Kim (Kim MK), Seung Hyun Ko (Ko SH), Miyeun Han (Han M), Dong Won Lee (Lee DW), Hyuk-Sang Kwon (Kwon HS), ,
Diabetes Metab J. 2020;44(1):3-10.   Published online 2020 Feb 21     DOI: https://doi.org/10.4093/dmj.2020.0004
Citations to this article as recorded by Crossref logo
Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
Diabetes Therapy.2021; 12(1): 171.     CrossRef
Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
Journal of Korean Medical Science.2021;[Epub]     CrossRef
KRCP's past and future path
Tae-Hyun Yoo
Kidney Research and Clinical Practice.2020; 39(3): 233.     CrossRef
Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
Yao Hu, Min Lei, Guibao Ke, Xin Huang, Xuan Peng, Lihui Zhong, Ping Fu
Frontiers in Endocrinology.2020;[Epub]     CrossRef
Pharmacotherapy for patients with diabetes mellitus
Joon Ho Moon, Soo Lim
Journal of the Korean Medical Association.2020; 63(12): 766.     CrossRef